MPD2143 COMMUNICABLE AND NON COMMUNICABLE DISEASE: PREVENTION MEASLES AND LEPROSY

PREVENTION OF MEASLES

Isolation - measles is highly contagious from about four days before to four days after the rash breaks out, people with measles shouldn't return to activities in which they interact with other people during this period.

It may also be necessary to keep nonimmunized people — siblings, for example — away from the infected person.

Vaccinate - Be sure that anyone who's at risk of getting the measles who hasn't been fully vaccinated receives the measles vaccine as soon as possible. This includes anyone born after 1957 who hasn't been vaccinated, as well as infants older than 6 months.

PREVENTION NEW INFECTIONS

Public education and community awareness are crucial to encourage individuals with leprosy and their families to undergo evaluation and treatment with MDT.
Household contacts of patients with leprosy should be monitored closely for the development of leprosy signs and symptoms.
A study demonstrated that prophylaxis with a single dose of rifampicin was 57% effective in preventing leprosy for the first two years in individuals who have close contact with newly diagnosed patients with leprosy.
There is currently no widely used standard for using medications for the prevention of leprosy.
Currently, there is no single commercial vaccine that confers complete immunity against leprosy in all individuals.
Several vaccines, including the BCG vaccine, provide variable levels of protection against leprosy in certain populations.